Frontiers in Immunology (Sep 2021)
Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes
- Tao Peng,
- Tao Peng,
- Khamsone Phasouk,
- Catherine N. Sodroski,
- Sijie Sun,
- Yon Hwangbo,
- Erik D. Layton,
- Lei Jin,
- Alexis Klock,
- Kurt Diem,
- Kurt Diem,
- Amalia S. Magaret,
- Amalia S. Magaret,
- Amalia S. Magaret,
- Lichen Jing,
- Kerry Laing,
- Alvason Li,
- Meei-Li Huang,
- Max Mertens,
- Christine Johnston,
- Christine Johnston,
- Christine Johnston,
- Keith R. Jerome,
- Keith R. Jerome,
- David M. Koelle,
- David M. Koelle,
- David M. Koelle,
- David M. Koelle,
- David M. Koelle,
- Anna Wald,
- Anna Wald,
- Anna Wald,
- Anna Wald,
- David M. Knipe,
- Lawrence Corey,
- Lawrence Corey,
- Lawrence Corey,
- Lawrence Corey,
- Jia Zhu,
- Jia Zhu,
- Jia Zhu
Affiliations
- Tao Peng
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Tao Peng
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Khamsone Phasouk
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Catherine N. Sodroski
- Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States
- Sijie Sun
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Yon Hwangbo
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Erik D. Layton
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Lei Jin
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Alexis Klock
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Kurt Diem
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Kurt Diem
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Amalia S. Magaret
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Amalia S. Magaret
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Amalia S. Magaret
- Department of Biostatistics, University of Washington, Seattle, WA, United States
- Lichen Jing
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- Kerry Laing
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- Alvason Li
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Meei-Li Huang
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Max Mertens
- Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States
- Christine Johnston
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Christine Johnston
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Christine Johnston
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- Keith R. Jerome
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Keith R. Jerome
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- David M. Koelle
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- David M. Koelle
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- David M. Koelle
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- David M. Koelle
- Department of Global Health, University of Washington School of Medicine, Seattle, WA, United States
- David M. Koelle
- Benaroya Research Institute, Seattle, WA, United States
- Anna Wald
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Anna Wald
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Anna Wald
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- Anna Wald
- Department of Epidemiology, University of Washington, Seattle, WA, United States
- David M. Knipe
- Department of Microbiology and Virology Program, Blavatnik Institute, Harvard Medical School, Boston, MA, United States
- Lawrence Corey
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Lawrence Corey
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Lawrence Corey
- Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
- Lawrence Corey
- Department of Global Health, University of Washington School of Medicine, Seattle, WA, United States
- Jia Zhu
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, United States
- Jia Zhu
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Jia Zhu
- Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, WA, United States
- DOI
- https://doi.org/10.3389/fimmu.2021.735643
- Journal volume & issue
-
Vol. 12
Abstract
Tissue-resident-memory T cells (TRM) populate the body’s barrier surfaces, functioning as frontline responders against reencountered pathogens. Understanding of the mechanisms by which CD8TRM achieve effective immune protection remains incomplete in a naturally recurring human disease. Using laser capture microdissection and transcriptional profiling, we investigate the impact of CD8TRM on the tissue microenvironment in skin biopsies sequentially obtained from a clinical cohort of diverse disease expression during herpes simplex virus 2 (HSV-2) reactivation. Epithelial cells neighboring CD8TRM display elevated and widespread innate and cell-intrinsic antiviral signature expression, largely related to IFNG expression. Detailed evaluation via T-cell receptor reconstruction confirms that CD8TRM recognize viral-infected cells at the specific HSV-2 peptide/HLA level. The hierarchical pattern of core IFN-γ signature expression is well-conserved in normal human skin across various anatomic sites, while elevation of IFI16, TRIM 22, IFITM2, IFITM3, MX1, MX2, STAT1, IRF7, ISG15, IFI44, CXCL10 and CCL5 expression is associated with HSV-2-affected asymptomatic tissue. In primary human cells, IFN-γ pretreatment reduces gene transcription at the immediate-early stage of virus lifecycle, enhances IFI16 restriction of wild-type HSV-2 replication and renders favorable kinetics for host protection. Thus, the adaptive immune response through antigen-specific recognition instructs innate and cell-intrinsic antiviral machinery to control herpes reactivation, a reversal of the canonical thinking of innate activating adaptive immunity in primary infection. Communication from CD8TRM to surrounding epithelial cells to activate broad innate resistance might be critical in restraining various viral diseases.
Keywords
- tissue-resident-memory T cells (TRM)
- innate antiviral response
- cell-intrinsic immunity
- IFI16 restriction factor
- tissue microenvironment
- human genital herpes